drugset / Trial / NCT00404742
A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to evaluate the safety and efficacy of LX211 as therapy in subjects with clinically quiescent non-infectious uveitis
Timeline
- Start
- 2007-01
- Primary completion
- 2008-11
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Voclosporin | Other / unclassified | 0.2 mg/kg | Oral |
| Comparator | Voclosporin | Other / unclassified | 0.4 mg/kg | Oral |
| Comparator | Voclosporin | Other / unclassified | 0.6 mg/kg | Oral |